GC Biopharma Corp. (KRX:006280)
South Korea · Delayed Price · Currency is KRW 132,300
-1,500 (-1.12%)
Last updated: Sep 9, 2025, 3:10 PM KST
GC Biopharma Market Cap
GC Biopharma has a market cap or net worth of 1.53 trillion as of September 8, 2025. Its market cap has decreased by -11.16% in one year.
Market Cap
1.53T
Enterprise Value
2.75T
Revenue
1.79T
Ranking
n/a
PE Ratio
20.73
Stock Price
132,300.00
Market Cap Chart
Since August 29, 1995, GC Biopharma's market cap has increased from 29.09B to 1.53T, an increase of 5,150.28%. That is a compound annual growth rate of 14.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 1,527.08B | -25.46% |
| Dec 30, 2024 | 2,048.67B | 43.03% |
| Dec 28, 2023 | 1,432.35B | -3.09% |
| Dec 29, 2022 | 1,478.01B | -40.60% |
| Dec 30, 2021 | 2,488.07B | -46.31% |
| Dec 30, 2020 | 4,633.75B | 206.42% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.31T |
| Celltrion | 37.23T |
| ALTEOGEN | 25.41T |
| Yuhan | 8,902.27B |
| SK Biopharmaceuticals | 8,551.81B |
| Peptron | 7,070.75B |
| PharmaResearch | 6,545.48B |
| ABL Bio | 5,621.23B |